Skip to content

Therapeutic measures in Sepsis patients.

Effect of supplementation of Albumin in patients of Sepsis with hypoalbuminemia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026429
Enrollment
80
Registered
2020-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R652- Severe sepsis

Interventions

Intervention1: Supplementation of Albumin: Supplementation of albumin in patients of sepsis with hypoalbuminemia 300ml of 20% Albumin solution on first day,then 200ml/day during hospital stay provide

Sponsors

Maulana Azad Medical College
Lead Sponsor
Dr Mradul Kumar Daga
Collaborator
Dr Sandeep Garg
Collaborator
Dr Smita Kaushik
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients of sepsis as per standard criteria laid down in sepsis guidelines 2016(sepsis 3) with hypoalbuminemia

Exclusion criteria

Exclusion criteria: Patients with chronic liver disease and chronic kidney disease Expected length of hospital stay is less then 3 days Evidence of fluid overload Patients of burns and trauma Immunocompromised status Patients of anaphylaxis and adrenal insufficiency Malnourishment and malabsorption

Design outcomes

Primary

MeasureTime frame
Disease outcome-Recovery/mortalityTimepoint: Less than or equal to one year

Secondary

MeasureTime frame
Duration of antibiotic therapy Timepoint: Less than or equal to one year;Duration of inotropic support and ventilation Timepoint: Less than or equal to one year;Length of Hospital stay Timepoint: Less than or equal to one year;Transfer to ICU and Length of ICU stayTimepoint: Less than or equal to one year

Countries

India

Contacts

Public ContactDr Monika G

Maulana Azad Medical College, New Delhi

drmraduldaga@gmail.com9968604273

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026